Today's Edition
ABU DHABI (WAM)
Under the Patronage of His Highness Sheikh Mansour bin Zayed Al Nahyan, Vice President, Deputy Prime Minister and Chairman of the Presidential Court, the 2nd annual ADSCC Bone Marrow Transplant and Cellular Therapy Congress 2024, organised by Abu Dhabi Stem Cells Center (ADSCC) will take place in Abu Dhabi from October 26-27 at Rixos Marina Abu Dhabi.
Following the success of its inaugural edition in November 2023which was attended by more than 1300 delegates from the healthcare sector and patients, the global health conference in its second edition continues to unite leading experts, researchers, scientists and practitioners worldwide to discuss the latest advancements and innovations in bone marrow transplant, cellular therapy, and regenerative medicine.
Supporting the strategic vision of ADSCC towards revolutionising healthcare globally, the congress hosts more than 35 international speakers from the US, Japan, UK, Germany, Spain, Switzerland, Italy, Singapore and the Middle East alongside 25 local speakers from prominent institutions in the UAE.
Until today, more than 2,000 delegate registered to attend the congress, which is supported by the Department of Culture and Tourism - Abu Dhabi, and endorsed by international institutions including Boston Children's Hospital, Indiana University Health and Josep Carreras Leukaemia Research Institute; academic partners including UAE University and Khalifa University, in addition to various medical societies including Emirates Oncology Society and UAE Rare Disease Society.
As a platform to showcase UAE’s recent advancements in cellular therapies, participants will have the chance to showcase pioneering research, present case studies and engage in interactive sessions driving innovation in the field.
The congress is targeted towards physicians in hematology, oncology, bone marrow transplant, apheresis, researchers and scientists, physicians with interest in regenerative medicine, nurses, medical students and academic faculty, pharmacists, as well as other clinicians.
Prof. Yendry Ventura, CEO of ADSCC, stated, "Within the rapidly evolving healthcare landscape, ADSCC remains firmly dedicated to advancing innovative care and research that align with the UAE's leadership directives. Our upcoming event in Abu Dhabi, held under the esteemed patronage of His Highness Sheikh Mansour bin Zayed Al Nahyan, reflects our commitment toward education and knowledge sharing in the field of cellular therapy.
"Our lineup of highly respected speakers, both locally and globally, are at the forefront of healthcare innovation and are set to share and discuss the latest in the field during our 2-day congress. Moreover, ADSCC’s hematologists and researchers will present our most recent breakthroughs at ADSCC as a leader in the regional and global landscape within the field of bone marrow transplant and regenerative medicine.”
Dr. Fatima Al Kaabi, Congress President and Executive Director of the Abu Dhabi Bone Marrow Transplant programme at ADSCC, added, “We are deeply honoured and grateful for the patronage of His Highness Sheikh Mansour bin Zayed Al Nahyan, which underscores the importance of this educational platform in advancing cellular therapy innovations and gene therapy. As a Center of Excellence in Hematopoietic Stem Cell Transplantation, ADSCC is committed toward introducing groundbreaking innovations in cellular therapy and making a lasting impact on the lives of patients in the UAE and worldwide."
"As we bring together global leaders in the field at this congress, we are confident that our collective efforts will drive significant progress in the fight against diseases that demand advanced treatment solutions such as blood disorders, autoimmune diseases, neurological disorders and others.”
With a renowned group of international speakers who have collectively over 395,000 citations and an average of H Index (a metric that measures both the productivity and citation impact of the publications) of over 51 which is considered high, the CME-accredited event will provide invaluable networking opportunities and interactive sessions focused on the challenges and opportunities within the field and the exploration of cutting-edge technologies and techniques.
The conference will run for two full days, offering a comprehensive program that covers a wide range of cutting-edge topics in bone marrow transplant, stem cell research and its clinical applications.
The agenda is thoughtfully structured into two parallel tracks, allowing attendees to choose sessions that best align with their interests and specialties.
